Contact
Please use this form to send email to PR contact of this press release:
Karolinska Development portfolio company Dilafor AB granted U.S. patent for Phase II drug tafoxiparin
TO:
Please use this form to send email to PR contact of this press release:
Karolinska Development portfolio company Dilafor AB granted U.S. patent for Phase II drug tafoxiparin
TO: